Research Article

Comparison of Febuxostat and Allopurinol in the Treatment of Patients with Chronic Kidney Disease Stage 3∼5 with Hyperuricemia

Table 4

Comparison of the incidence of adverse reactions between the two groups after treatment [n (%)].

GroupnRashAbnormal liver functionGastrointestinal functional responseAllergic vasculitisThe incidence of adverse reactions

Control group50243211 (22.00)
Experimental group5011215 (10.00)
t value5.31
value< 0.05